| Product Code: ETC11389230 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Anticoagulants Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Anticoagulants Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Anticoagulants Market - Industry Life Cycle |
3.4 Ireland Anticoagulants Market - Porter's Five Forces |
3.5 Ireland Anticoagulants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Anticoagulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Ireland Anticoagulants Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Ireland Anticoagulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Ireland |
4.2.2 Growing awareness about the benefits of anticoagulants in preventing blood clots |
4.2.3 Rising geriatric population in Ireland requiring anticoagulant therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of anticoagulant drugs in Ireland |
4.3.2 High cost associated with anticoagulant therapy leading to affordability issues for patients |
5 Ireland Anticoagulants Market Trends |
6 Ireland Anticoagulants Market, By Types |
6.1 Ireland Anticoagulants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Anticoagulants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Ireland Anticoagulants Market Revenues & Volume, By Direct Oral Anticoagulants, 2021 - 2031F |
6.1.4 Ireland Anticoagulants Market Revenues & Volume, By Vitamin K Antagonists, 2021 - 2031F |
6.1.5 Ireland Anticoagulants Market Revenues & Volume, By Heparin, 2021 - 2031F |
6.2 Ireland Anticoagulants Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Ireland Anticoagulants Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Ireland Anticoagulants Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Ireland Anticoagulants Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ireland Anticoagulants Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.3 Ireland Anticoagulants Market Revenues & Volume, By Atrial Fibrillation, 2021 - 2031F |
6.3.4 Ireland Anticoagulants Market Revenues & Volume, By Pulmonary Embolism, 2021 - 2031F |
7 Ireland Anticoagulants Market Import-Export Trade Statistics |
7.1 Ireland Anticoagulants Market Export to Major Countries |
7.2 Ireland Anticoagulants Market Imports from Major Countries |
8 Ireland Anticoagulants Market Key Performance Indicators |
8.1 Average prescription rate of anticoagulants per capita in Ireland |
8.2 Percentage increase in usage of novel oral anticoagulants (NOACs) compared to traditional anticoagulants |
8.3 Number of clinical trials for anticoagulant drugs conducted in Ireland |
8.4 Patient adherence rate to anticoagulant therapy |
8.5 Rate of adverse events reported related to anticoagulant usage in Ireland |
9 Ireland Anticoagulants Market - Opportunity Assessment |
9.1 Ireland Anticoagulants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Anticoagulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Ireland Anticoagulants Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Ireland Anticoagulants Market - Competitive Landscape |
10.1 Ireland Anticoagulants Market Revenue Share, By Companies, 2024 |
10.2 Ireland Anticoagulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here